๐Ÿ”ฌ DUDU RESEARCH CENTER
PRIVATE
RESEARCHโ€บHealth Careโ€บVRTX

VRTX

US

Vertex Pharmaceuticals Incorporated

Health Careยท Biotechnology
$433.07
Target: $547.72
โ–ฒ 26.5% Upside

Sector: [[Sectors/Health Care]] | [[ValueChains/Health Care/Biotechnology]]

Vertex Pharmaceuticals Incorporated (VRTX) ๋ถ„์„ ๋ฆฌํฌํŠธ

์ฑ…์ž„ ๋ฒ”์œ„(๊ฐœ๋ณ„์ข…๋ชฉ ๋ ˆ๋ฒจ): ํ•ด๋‹น ๊ธฐ์—…์˜ ํˆฌ์ž ๋…ผ๋ฆฌ/ํŒฉํŠธ/๋ฐธ๋ฅ˜/๋ฆฌ์Šคํฌ๋ฅผ ์ •๋ฆฌํ•œ๋‹ค.
์ƒ์œ„ ๊ตฌ์กฐ๋Š” sector_en/value_chain์œผ๋กœ ์—ฐ๊ฒฐํ•˜๊ณ , ํ•ต์‹ฌ ๊ธฐ์ˆ ์€ spotlight_tech(์ตœ๋Œ€ 2)๋กœ๋งŒ ์—ฐ๊ฒฐํ•œ๋‹ค.

๐Ÿ“‹ ํˆฌ์ž ๋…ผ๋ฆฌ

  • ์ถ”์ฒœ: Watch
  • ํ•ต์‹ฌ ๊ทผ๊ฑฐ: Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfus...

๐Ÿ“Š ํŒฉํŠธ ๋ฐ์ดํ„ฐ

์žฌ๋ฌด ์š”์•ฝ (FY2025)

  • ๋งค์ถœ: $12.0B (USD)
  • ์˜์—…์ด์ต: $4.6B
  • ์ˆœ์ด์ต: $4.0B
  • FCF: $3.2B

๊ฐ€๊ฒฉ/๋ฉ€ํ‹ฐํ”Œ (2026-03-28)

  • ํ˜„์žฌ๊ฐ€: $433.07
  • ์‹œ๊ฐ€์ด์•ก: $110.0B
  • PER(TTM): 28.23x / Forward PE: 19.73x
  • PBR: 5.89x / PS: 9.17x / EV/EBITDA: 22.75x
  • 52์ฃผ ๋ฒ”์œ„: $362.50 ~ $513.98

๐ŸŽฏ ๊ฐ€์น˜ ํ‰๊ฐ€

  • ๋ชฉํ‘œ๊ฐ€ ๋ฒ”์œ„: ๋”ฅ๋ฆฌ์„œ์น˜ ์ „ ๋ฏธ์„ค์ •
  • ํ˜„์žฌ๊ฐ€ ๋Œ€๋น„ ํ‰๊ฐ€: ์ถ”๊ฐ€ ๋ถ„์„ ํ•„์š”

๐Ÿšจ ๋ฆฌ์Šคํฌ

  • CF ์‹œ์žฅ ํฌํ™”: ๋‚ญํฌ์„ฑ ์„ฌ์œ ์ฆ ํ™˜์ž pool ํ•œ๊ณ„๋กœ ์žฅ๊ธฐ ์„ฑ์žฅ์„ฑ ์ œ์•ฝ
  • ํŒŒ์ดํ”„๋ผ์ธ ์ง‘์ค‘: CRISPR/์‹ ์žฅ์งˆํ™˜ ๋“ฑ ์‹ ๊ทœ ํŒŒ์ดํ”„๋ผ์ธ ์˜์กด๋„ ์ฆ๊ฐ€
  • ์•ฝ๊ฐ€ ์••๋ฐ•: ๊ณ ๊ฐ€ ํฌ๊ท€์งˆํ™˜ ์น˜๋ฃŒ์ œ์— ๋Œ€ํ•œ ๋ณดํ—˜๊ธ‰์—ฌ ์ œํ•œ ๋ฆฌ์Šคํฌ

๐Ÿ”ฎ Bull/Bear ์‹œ๋‚˜๋ฆฌ์˜ค

Bull Case (์ตœ์ )

  • ๊ฐ€์ •: ํ•ต์‹ฌ ์‚ฌ์—… ์„ฑ์žฅ ์ง€์† ๋ฐ ์‹ ๊ทœ ์‹œ์žฅ ๊ฐœ์ฒ™
  • ๋ชฉํ‘œ๊ฐ€: ๋ฏธ์„ค์ •
  • ํ™•๋ฅ : 30%

Base Case (์ค‘๋ฆฝ)

  • ๊ฐ€์ •: ํ˜„์žฌ ์„ฑ์žฅ ๊ถค๋„ ์œ ์ง€
  • ๋ชฉํ‘œ๊ฐ€: ๋ฏธ์„ค์ •
  • ํ™•๋ฅ : 50%

Bear Case (์ตœ์•…)

  • ๊ฐ€์ •: ์—…ํ™ฉ ์•…ํ™” ๋ฐ ๊ฒฝ์Ÿ ์‹ฌํ™”
  • ๋ชฉํ‘œ๊ฐ€: ๋ฏธ์„ค์ •
  • ํ™•๋ฅ : 20%

๐Ÿ› ๏ธ ๊ธฐ์ˆ  ํ”„๋กœํŒŒ์ผ (ํ•ด๋‹น์‹œ)

  • ํ•ต์‹ฌ ๊ธฐ์ˆ : Biotechnology
  • ์‹œ์žฅ ์ ์šฉ: ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ ์˜ˆ์ •
  • ๊ฒฝ์Ÿ ์šฐ์œ„: ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ ์˜ˆ์ •
  • ์‹œ์žฅ ์ „๋ง(TAM/SAM/SOM): ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ ์˜ˆ์ •

๐Ÿ‘ฅ ์ปค๋ฎค๋‹ˆํ‹ฐ ํŽ„์Šค

  • Reddit/SeekingAlpha/X ๊ฐ์„ฑ: ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ
  • ์ฃผ์š” ๋…ผ์Ÿ์ : ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ

๐ŸŒ ๋งคํฌ๋กœ ์ž„ํŒฉํŠธ

  • ๊ธ€๋กœ๋ฒŒ ์ด๋ฒคํŠธ ์˜ํ–ฅ: ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ
  • ๊ณต๊ธ‰๋ง/์›์ž์žฌ ๋ฆฌ์Šคํฌ: ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ

๐Ÿ“ˆ ์ฐจํŠธ ๋ถ„์„

  • ๊ธฐ์ˆ ์  ์‹ ํ˜ธ: ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ
  • ์ฃผ์š” ์ €ํ•ญ/์ง€์ง€: ๋”ฅ๋ฆฌ์„œ์น˜ ํ›„ ์—…๋ฐ์ดํŠธ

๐Ÿ“ ๊ด€๋ฆฌ ๋…ธํŠธ

๋ณ€๊ฒฝ ์ด๋ ฅ

  • 2026-03-28: yfinance ์‹ค๋ฐ์ดํ„ฐ ์ผ๊ด„ ์ •๋น„ (์ž๋™ํ™”)

๊ด€์‹ฌ๋„ ๋ณ€ํ™”

  • 2026-03-28: ์ดˆ๊ธฐ ์ •๋น„ ์™„๋ฃŒ, ๋”ฅ๋ฆฌ์„œ์น˜ ๋Œ€๊ธฐ

๐Ÿ”— ๊ด€๋ จ ์ž๋ฃŒ

๊ด€๋ จ ๊ธฐ์ˆ  ๋ถ„์„

TABLE ๊ธฐ์ˆ ๋ช… AS ๊ธฐ์ˆ , TRL_์ˆ˜์ค€ AS TRL, ์นดํ…Œ๊ณ ๋ฆฌ AS ์นดํ…Œ๊ณ ๋ฆฌ, ๋‹ค์Œ_๊ฒ€ํ† ์ผ AS ๋‹ค์Œ๊ฒ€ํ† 
FROM "Research_DB/๊ธฐ์ˆ "
WHERE contains(๊ด€๋ จ_๊ธฐ์—…, this.file.link) OR contains(๊ด€๋ จ_๊ธฐ์—…, this.ํšŒ์‚ฌ๋ช…)
SORT TRL_์ˆ˜์ค€ DESC

๋™์ผ ์„นํ„ฐ ๊ธฐ์—… ๋น„๊ต (DB ๋ ˆ์ด์–ด ๊ธฐ์ค€: sector_en)

TABLE company AS ํšŒ์‚ฌ, ticker AS ํ‹ฐ์ปค, ๊ด€์‹ฌ๋„ AS ๊ด€์‹ฌ๋„, ๊ด€์‹ฌ๋„_์ ์ˆ˜ AS ์ ์ˆ˜, ์ƒํƒœ AS ์ƒํƒœ
FROM "Research_DB/๊ฐœ๋ณ„์ข…๋ชฉ"
WHERE sector_en = this.sector_en AND file.name != this.file.name
SORT ๊ด€์‹ฌ๋„_์ ์ˆ˜ DESC
LIMIT 5

๐Ÿ“š ์ถœ์ฒ˜

  • ๋ฐ์ดํ„ฐ: Yahoo Finance (yfinance 2026-03-28)
  • ํŒฉํŠธ์ฒดํฌ: ๊ณต์‹ ๋ฐœํ‘œ ๊ธฐ์ค€
FINANCIALS
Market Cap110.01B
Revenue TTM12.00B
Op Margin39.6%
P/E (Fwd)19.7x
P/S9.2x
EV/EBITDA21.7x
META
Last Reviewed2026-03-28
Price Date2026-03-29
KPI Stagemonitoring
Statusactive